Inclusion Criteria:  Aged 18-65 years, of any gender. Consulted at their general practice for type 2 diabetes in the previous 12 months. Residing within England (due to delivery difficulties from covid-19). Self-reported confirmed diagnosis of type 2 diabetes. Self-reported stable medication regime for diabetes for at least one month. Sufficient command of English to complete questionnaires. Patients willing to participate in the study and be randomised into one of the two study groups.  Exclusion Criteria:  Patients with type 1 diabetes. Patients with previous experience of using PEMF devices. Patients residing outside England. Patients with electronic implants such as pacemakers. Patients with an electro-cardio implant. Patients who have any electronic heart or lung apparatus. Patients who are pregnant. Patients who have a malignant tumour. Patients who are receiving high-level treatment. Patients who have a life-threatening illness.